CPMD 最新10-Q变化
将 CPMD 最新的定期申报(10-K/10-Q)与上一份同类型申报逐章节对比:每个章节新增/删除的段落数与原文摘录。全部为确定性文本对比——无相似度评分、无方向判断、非投资建议。
对比:10-Q · 2026-08-18 与上一份 10-Q · 2026-05-20
| 章节 | 结果 | 新增 | 删除 | 微调 | 未变 |
|---|---|---|---|---|---|
| 管理层讨论与分析 | 文字有新增/删除 | +97 | −106 | ~10 | 7 |
| 市场风险(第3项) | 文字有新增/删除 | +1 | −122 | 0 | 0 |
| 控制与程序 | 文字有新增/删除 | +17 | −122 | 0 | 0 |
| 法律诉讼 | 文字有新增/删除 | +6 | −122 | 0 | 0 |
| 风险因素 | 本季全文重述 | +1 | 0 | 0 | 0 |
| 其他信息 | 文字有新增/删除 | +1 | −122 | 0 | 0 |
计数单位为段落;"新增/删除"指相对上一份文件新增/删除的文字,不含方向或好坏判断。
代表性摘录
每个章节最多 5 条、每条约 300 字符的原文摘录,直接来自两份 SEC 文件。
管理层讨论与分析
相对上期新增的文字 · 来源:10-Q · 2026-08-18
The following discussion and analysis of the Company’s financial condition and results of operations as at and for the three and six months ended June 30, 2026 and 2025 should be read together with the Company’s financial statements and related notes appearing elsewhere in this Quarterly Report on F…
In connection with, and because we desire to take advantage of, the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995, we caution readers regarding certain forward-looking statements in the following discussion and elsewhere in this Report and in any other statement ma…
This Quarterly Report on Form 10-Q includes a number of “forward-looking statements” within the meaning of the U.S. Private Securities Litigation Reform Act of 1995, including statements concerning anticipated financial results and developments of our operations in future periods that reflect manage…
· risks associated with the Company's history of losses and need for additional financing,
· risks associated with increased costs affecting its financial condition,
相对上期删除的文字 · 来源:10-Q · 2026-05-20
Management’s Discussion and Analysis of Financial Condition and Results of Operations/Plan of Operation
Preferred shares series A, $1.00 par value, 100,000 shares authorized, 74,416 issued and outstanding as at March 31, 2026 and December 31, 2025
Preferred shares series B, $1.00 par value, 3,000,000 shares authorized, 455,000 shares issued and outstanding as at March 31, 2026 and December 31, 2025
Preferred shares series C, $1.00 par value, 100,000 shares authorized, 100,000 shares issued and outstanding as at March 31, 2026 and December 31, 2025
The accompanying notes are an integral part of these unaudited condensed interim consolidated financial statements.
市场风险(第3项)
相对上期新增的文字 · 来源:10-Q · 2026-08-18
Item 2 Unregistered Sales of Equity Securities and Use of Proceeds 45
相对上期删除的文字 · 来源:10-Q · 2026-05-20
Preferred shares series A, $1.00 par value, 100,000 shares authorized, 74,416 issued and outstanding as at March 31, 2026 and December 31, 2025
Preferred shares series B, $1.00 par value, 3,000,000 shares authorized, 455,000 shares issued and outstanding as at March 31, 2026 and December 31, 2025
Preferred shares series C, $1.00 par value, 100,000 shares authorized, 100,000 shares issued and outstanding as at March 31, 2026 and December 31, 2025
The accompanying notes are an integral part of these unaudited condensed interim consolidated financial statements.
CONDENSED INTERIM CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS
控制与程序
相对上期新增的文字 · 来源:10-Q · 2026-08-18
Our management, with the participation of our Chief Executive Officer (“CEO”) and Chief Financial Officer (“CFO”), has evaluated the effectiveness of our disclosure controls and procedures (as such term is defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended…
These controls are designed to ensure that information required to be disclosed in the reports we file or submit pursuant to the Securities Exchange Act of 1934 is recorded, processed, summarized and reported within the time periods specified in the rules and forms of the SEC, and that such informat…
Based on this evaluation, our CEO and CFO concluded that our disclosure controls and procedures were not effective as at June 30, 2026, solely due to the material weakness in internal control over financial reporting described below.
Our management, including our CEO and CFO, does not expect that our disclosure controls and procedures will prevent all error and all fraud. A control system, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are…
During the quarter ended June 30, 2026, management continued its efforts to improve the Company's internal control over financial reporting and to remediate the material weakness described below. Remediation activities undertaken during the quarter included enhanced review procedures over significan…
相对上期删除的文字 · 来源:10-Q · 2026-05-20
Preferred shares series A, $1.00 par value, 100,000 shares authorized, 74,416 issued and outstanding as at March 31, 2026 and December 31, 2025
Preferred shares series B, $1.00 par value, 3,000,000 shares authorized, 455,000 shares issued and outstanding as at March 31, 2026 and December 31, 2025
Preferred shares series C, $1.00 par value, 100,000 shares authorized, 100,000 shares issued and outstanding as at March 31, 2026 and December 31, 2025
The accompanying notes are an integral part of these unaudited condensed interim consolidated financial statements.
CONDENSED INTERIM CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS
法律诉讼
相对上期新增的文字 · 来源:10-Q · 2026-08-18
As part of the Company’s acquisition of AMS in 2018, the Company is working with legal counsel to determine whether it has claims against Steven Barber arising from his alleged default under the consulting agreement entered into in connection with the acquisition (the “Consulting Agreement”). In Jan…
No decision on whether to proceed on either of these situations has been reached as at the date of this Report, but the Company does not believe that these situations present a probability of material risk. As at June 30, 2026, the Company has an outstanding payable of $549,780 included in accounts …
On July 18, 2024, Deloitte filed a civil claim in the Alberta Court of Justice alleging a breach of contract. Deloitte was engaged by the Company to assist with fiscal year 2022 finance backfill and diagnostic services and, in accordance with a signed engagement letter dated August 29, 2022, perform…
The plaintiffs have filed a lawsuit against the Company alleging wrongful termination, related misconduct, and unpaid compensation. The plaintiffs seek $3 million in compensatory damages and an additional $3 million in punitive damages. During the six months ended June 30, 2026, the Company particip…
The Company issued two promissory notes to Astor Street LLC in January 2021 and granted Astor Street LLC a security interest in all of the Company’s present and after-acquired assets. Astor Street LLC commenced a claim to recover amounts owing of CAD $312,303 in April 2022 and obtained a default jud…
相对上期删除的文字 · 来源:10-Q · 2026-05-20
Preferred shares series A, $1.00 par value, 100,000 shares authorized, 74,416 issued and outstanding as at March 31, 2026 and December 31, 2025
Preferred shares series B, $1.00 par value, 3,000,000 shares authorized, 455,000 shares issued and outstanding as at March 31, 2026 and December 31, 2025
Preferred shares series C, $1.00 par value, 100,000 shares authorized, 100,000 shares issued and outstanding as at March 31, 2026 and December 31, 2025
The accompanying notes are an integral part of these unaudited condensed interim consolidated financial statements.
CONDENSED INTERIM CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS
风险因素
相对上期新增的文字 · 来源:10-Q · 2026-08-18
Item 2 Unregistered Sales of Equity Securities and Use of Proceeds 45
其他信息
相对上期新增的文字 · 来源:10-Q · 2026-08-18
During the three and six months ended June 30, 2026, no director or officer adopted or terminated any Rule 10b5-1 trading arrangement or non-Rule 10b5-1 trading arrangement, as each term is defined in Item 408(a) of Regulation S-K.
相对上期删除的文字 · 来源:10-Q · 2026-05-20
Preferred shares series A, $1.00 par value, 100,000 shares authorized, 74,416 issued and outstanding as at March 31, 2026 and December 31, 2025
Preferred shares series B, $1.00 par value, 3,000,000 shares authorized, 455,000 shares issued and outstanding as at March 31, 2026 and December 31, 2025
Preferred shares series C, $1.00 par value, 100,000 shares authorized, 100,000 shares issued and outstanding as at March 31, 2026 and December 31, 2025
The accompanying notes are an integral part of these unaudited condensed interim consolidated financial statements.
CONDENSED INTERIM CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS
如何读 10-Q 的风险因素(第 1A 项)
10-Q 的风险因素章节有三种常见形态,本页按其一分类展示:
- 指向(pointer) — 公司仅声明"无重大变化"并指向年度 10-K 的完整风险因素;本季没有自己的风险文本可对比。
- 部分更新(partial) — 公司写明"除下述外无重大变化",只更新部分风险;摘录展示的正是本季新增的内容。
- 全文重述(restated) — 本季重新给出完整风险因素。若上一季只是"指向",则无法逐段对比,本页会将其标为"本季全文重述"。
这只是对文件结构的客观描述,不构成对风险高低的判断。
数据来自 SEC EDGAR 两份申报文件的文本级对比 · 确定性计算(无 AI 生成内容)· 仅供参考 · 非投资建议